Polymorphisms of the KCNQ1 gene are associated with the therapeutic responses of sulfonylureas in Chinese patients with type 2 diabetes. - Wikidata - awgldk - TriplyDB

Polymorphisms of the KCNQ1 gene are associated with the therapeutic responses of sulfonylureas in Chinese patients with type 2 diabetes.

Polymorphisms of the KCNQ1 gene are associated with the therapeutic responses of sulfonylureas in Chinese patients with type 2 diabetes.

http://www.wikidata.org/entity/Q37571899

about

Genetic Approaches to the Study of Gene Variants and Their Impact on the Pathophysiology of Type 2 Diabetes.

P2860

Q49970697-AFE3F03D-B668-4D6B-90A8-09701EA7109F

P2860

Polymorphisms of the KCNQ1 gene are associated with the therapeutic responses of sulfonylureas in Chinese patients with type 2 diabetes.

http://www.wikidata.org/entity/Q37571899

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Polymorphisms of the KCNQ1 gen ...... patients with type 2 diabetes.

@en

Polymorphisms of the KCNQ1 gen ...... patients with type 2 diabetes.

@nl

type

label

Polymorphisms of the KCNQ1 gen ...... patients with type 2 diabetes.

@en

Polymorphisms of the KCNQ1 gen ...... patients with type 2 diabetes.

@nl

prefLabel

Polymorphisms of the KCNQ1 gen ...... patients with type 2 diabetes.

@en

Polymorphisms of the KCNQ1 gen ...... patients with type 2 diabetes.

@nl

P1433

Q37571899-85355BB2-BDEF-4964-B115-AB278FA802BC

P1476

Q37571899-EC1B3272-6CF3-475E-AB43-65AB04ED159A

P2093

Q37571899-1D4C4F59-CB6F-412F-A112-792B6E82B843

Q37571899-616087FC-99ED-4D11-A030-1321EDD9A838

Q37571899-7F3D4F48-A21B-4A87-89E0-4BB9335D533F

Q37571899-8265EBD4-A05E-4934-B00A-FF5D8C36C405

Q37571899-86EB7B68-F9DB-4994-A75A-58BDBD13DC27

Q37571899-9BEE60D0-80A7-41BD-AE67-DB47DA09ED0C

Q37571899-C916C7D7-5DC5-4647-8C5F-8E8B1C557124

Q37571899-D24C5A45-F036-4CB5-BCF2-78393B4C6701

Q37571899-F433B342-97B2-44A9-8F12-6ABA8C6B1F38

P2860

Q37571899-0893CFA8-DCBB-4FE7-9FBF-3A771D8C4C13

Q37571899-198080E4-835F-46CC-8D1F-0BA47FF93F9C

Q37571899-22638AFC-CE7C-490F-B4B8-1A27A5035A4E

Q37571899-25F49566-C20D-4525-91EF-663FF6ECA861

Q37571899-27C6566D-8EB1-41AE-9D5D-17492A8B3CC3

Q37571899-27FAF6B6-C2F8-4AC8-81C1-2472EB288B03

Q37571899-335E45B7-545C-4FD7-B409-AF02CCC4B842

Q37571899-38218A7D-1944-4D81-A68B-0DB96DF43762

Q37571899-3934F059-C1CF-4ACE-8928-CA84F9C3B09A

Q37571899-3B32F134-21DC-4930-B191-BCDF4368A52B

P2888

Q37571899-802E0ED2-72E3-45C8-A9CC-6F5BAC635A9C

P304

Q37571899-F4228C27-373A-4AF8-BA94-6614C05E18E0

P31

Q37571899-009C975C-7EFD-4B01-B06F-D879DBBFC735

P356

Q37571899-5B442148-F657-4DBE-B15E-4D6C0C941162

P433

Q37571899-6024BE03-7EAE-4FA9-B48D-C6083D3591E7

P478

Q37571899-7AE0923F-D0E6-46E1-95EF-3C3BA8655406

P50

Q37571899-FCC73A07-A79C-47E9-BFF3-B97AEA38328F

P577

Q37571899-083C2D6B-DCBC-41D2-B2EC-17DFAC7390DD

P698

Q37571899-01A1C8EA-C9FE-4876-83DE-4F7D4C9B6C76

P921

Q37571899-1A42853C-E4EE-4F19-B812-E21A818A9B3F

P932

Q37571899-CD862699-85FD-48BD-913B-8D58F08164C3

P356

P1433

Acta Pharmacologica Sinica

P1476

Polymorphisms of the KCNQ1 gen ...... patients with type 2 diabetes.

@en

P2093

Feng Jiang

http://www.w3.org/2001/XMLSchema#string

Jun Yin

http://www.w3.org/2001/XMLSchema#string

Miao Chen

http://www.w3.org/2001/XMLSchema#string

Qing Li

http://www.w3.org/2001/XMLSchema#string

Rong Zhang

http://www.w3.org/2001/XMLSchema#string

Ting-Ting Tang

http://www.w3.org/2001/XMLSchema#string

Wei-Ping Jia

http://www.w3.org/2001/XMLSchema#string

Xiang Cheng

http://www.w3.org/2001/XMLSchema#string

Yu-Qian Bao

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trials

GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients

K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current

Common variants in the type 2 diabetes KCNQ1 gene are associated with impairments in insulin secretion during hyperglycaemic glucose clamp

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load

Members of the Kv1 and Kv2 voltage-dependent K(+) channel families regulate insulin secretion.

The emerging genetic architecture of type 2 diabetes

A 16-week study to compare the effect of vildagliptin versus gliclazide on postprandial lipoprotein concentrations and oxidative stress in patients with type 2 diabetes inadequately controlled with metformin monotherapy.

P2888

P304

80-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/APS.2016.103

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27694910

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

5220536

http://www.w3.org/2001/XMLSchema#string